Study: Transplanted neurons remain healthy long-term in Parkinson's

06/5/2014 | HealthDay News

Scientists reported in the journal Cell Reports that transplanted neurons in all five Parkinson's disease patients in their study who received fetal tissue-derived dopamine-producing neurons four to 14 years ago appeared healthy, with no signs of disease-associated deterioration. Findings suggest that stem cells can be a source of dopamine-producing neurons and that stem-cell transplant is a viable therapy.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY